Breast cancer remodels lymphatics in sentinel lymph nodes

Dominik Eichin, Diana Lehotina, Anni Kauko, Maki Uenaka, Meri Leppänen, Kati Elima, Minna Piipponen, Tapio Lönnberg, Pia Boström, Ilkka Koskivuo, Tero Aittokallio, Maija Hollmén, Akira Takeda, Sirpa Jalkanen

Nature Communications (2025)

Published on December 5, 2025

DOI: https://doi.org/10.1038/s41467-025-64981-z

Abstract

Abstract Cancer metastasis to sentinel lymph nodes (LNs) is often the first marker of potential disease progression. Although it is recognized that tumor-induced lymphangiogenesis facilitates metastasis into LNs in murine models, tumor-induced alterations in human lymphatic vessels remain obscure. Here we use single-cell RNA sequencing and high-resolution spatial transcriptomics to profile lymphatic endothelial cell (LEC) subsets in paired metastatic and non-metastatic LNs obtained from female patients with treatment-naïve breast cancer. Tumor metastasis decreases immunoregulatory LEC subsets, such as PD-L1 + subcapsular sinus LECs, while inducing an increase in capillary-like CD200 + HEY1 + LECs. Matrix Gla protein (MGP) is the most upregulated gene in metastatic LN LECs, and its expression on LECs is TGF-β and VEGF dependent. Upregulated MGP promotes cancer cell adhesion to LN lymphatics. Thus, breast cancer cell metastasis to LNs remodels LEC subsets in human LNs and escalates MGP expression, potentially facilitating cancer cell dissemination through the lymphatic system.
← Back to Publications
I. Tamanna et al. • Aug 10, 2026 • Journal of Proteome Research
Abstract Food residues that bypass human digestion are further digested by gut microbes, leading to the production of diverse metabolites,...
J. Grist et al. • May 4, 2026 • Journal of Neuroinflammation
Abstract Given the prevalence of metabolic perturbations in a variety of neurological and neurodegenerative diseases, understanding and monitoring brain metabolism...
M. Gluud et al. • Mar 8, 2026 • Allergy
ABSTRACT Background Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma...